Shares of Extendicare Inc. (TSE:EXE - Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as C$14.59 and last traded at C$14.57, with a volume of 37925 shares. The stock had previously closed at C$14.50.
Analyst Ratings Changes
EXE has been the subject of a number of research analyst reports. Cormark upgraded Extendicare to a "moderate buy" rating in a research report on Wednesday, February 19th. BMO Capital Markets raised their price target on Extendicare from C$11.00 to C$13.50 in a report on Monday, March 3rd. Finally, TD Securities upped their price objective on Extendicare from C$10.50 to C$13.00 and gave the stock a "hold" rating in a report on Monday, March 3rd.
Get Our Latest Report on Extendicare
Extendicare Trading Up 1.1 %
The company has a 50-day moving average of C$13.18 and a 200 day moving average of C$11.30. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The company has a market cap of C$1.16 billion, a PE ratio of 17.65 and a beta of 1.26.
Extendicare Increases Dividend
The business also recently declared a monthly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, May 15th will be issued a dividend of $0.042 per share. This represents a $0.50 annualized dividend and a yield of 3.64%. The ex-dividend date is Wednesday, April 30th. This is a positive change from Extendicare's previous monthly dividend of $0.04. Extendicare's dividend payout ratio is presently 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
